Non-alcoholic fatty liver disease in type 2 diabetes: Emerging evidence of benefit of peroxisome proliferator-activated receptors agonists and incretin-based therapies

doi:10.5662/wjm.v14.i2.91319

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3489)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

154

HTML

2181

Figures (1-4)

357

Tables (1-3)

344

Sum=3036

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

215

Sum=305

Jun 20, 2024 (publication date) through May 7, 2025

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Methodology

ISSN

2222-0682

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Methodol. Jun 20, 2024; 14(2): 91319
Published online Jun 20, 2024. doi: 10.5662/wjm.v14.i2.91319

Full Size Figure Download Figure

Figure 4 Pleotropic effects of glucagon-like peptide 1 and its effect of several organ systems in systematic inflammation characteristic of nonalcoholic steatohepatitis. GLP-1: Glucagon-like peptide 1.

Citation: Pramanik S, Pal P, Ray S. Non-alcoholic fatty liver disease in type 2 diabetes: Emerging evidence of benefit of peroxisome proliferator-activated receptors agonists and incretin-based therapies. World J Methodol 2024; 14(2): 91319
URL: https://www.wjgnet.com/2222-0682/full/v14/i2/91319.htm
DOI: https://dx.doi.org/10.5662/wjm.v14.i2.91319